I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Operating Expenses Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Operating Expenses
-kr111.9m
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Operating Expenses
-kr1.8B
CAGR 3-Years
-50%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Operating Expenses
-kr1.2B
CAGR 3-Years
-27%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Operating Expenses
-kr1.2B
CAGR 3-Years
-87%
CAGR 5-Years
-88%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Operating Expenses
-kr58m
CAGR 3-Years
-31%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Operating Expenses
-kr27.5m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Operating Expenses?
Operating Expenses
-111.9m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Operating Expenses amounts to -111.9m SEK.

What is InDex Pharmaceuticals Holding AB's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-9%

Over the last year, the Operating Expenses growth was -105%. The average annual Operating Expenses growth rates for InDex Pharmaceuticals Holding AB have been -18% over the past three years , -9% over the past five years .

Back to Top